COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2021

Aug 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2021-08-10

Reporting Person: Ciaffoni Joseph (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-10	Common Stock	F	1386	$19.03	Disposed	264994	Direct

Footnotes

F1: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.